Sex, statins, and diabetes

Cleveland Clinic Journal of Medicine

Volumn 80, Issue 3, 2013, Pages 187-

  Thacker, Holly L ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

CHEMICALLY INDUCED; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS;

DIABETES MELLITUS, TYPE 2; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;

EID: 84875800932     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.80c.03004     Document Type: Letter

References (5)

1. Rocco M. Statins and diabetes risk: fact, fiction, and clinical implications. Cleve Clin J Med 2012; 79:883-893.
2. Culver AL, Ockene IS, Balasubramanian R, et al. Statin use and risk of diabetes mellitus in postmenopausal women in the Women's Health Initiative. Arch Intern Med 2012; 172:144-152.
3. Freeman DJ, Norrie J, Sattar N, et al. Pravastatin and the development of diabetes mellitus: evience for a protective treatment effect in WOSCOPS. Circulation 2001; 103:357-362.
4. Gutierrez J, Ramirez G, Rundek T, et al. Statin therapy in the prevention of recurrent cardiovascular events. A sexbased meta-analysis. Arch Intern Med 2012; 172:909-919.
5. Schierbeck LL, Rejnmark L, Tofteng CL, et al. Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomized trial. BMJ 2012; 345:e6409.